Englewood, Colorado Clinical Trials

A listing of Englewood, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Colorado Blood Cancer Institute (CBCI)
 (5.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

multicentric castleman disease
stage iiia lung squamous cell carcinoma ajcc v7
immunohistochemistry
stage iiia lung cancer ajcc v7
squamous cell lung carcinoma
Mountain Blue Cancer Care Center - Swedish
 (1.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"  

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD) Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation To continue to assess the …

sleep disturbance
atopy
dupilumab
dermatitis
atopic
Investigational Site Number 8400005
 (4.9 away)
  • 0 views
  • 19 Feb, 2024
  • +41 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (5.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

prostate cancer
metastatic cancer
rimiducid
metastatic disease
metastatic castration-resistant prostate cancer
Sarah Cannon Research Institute at HealthONE
 (5.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Safety and Effectiveness of the PXL-Platinum 330 System

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

keratoconus
riboflavin
terrien's marginal degeneration
radial keratotomy
Colorado Eye Consultants/Corneal Consultants of Colorado
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (5.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (5.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.

biospecimen collection
Porter Adventist Hospital
 (2.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +380 other locations
RETHINK REFLUX Registry

The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.

reflux
linx procedure
Institute of Esophageal and Reflux Surgery
 (1.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations